Conference Coverage

EndoPredict results reflected tumor response to neoadjuvant therapy

Publish date: January 2, 2018

 

REPORTING FROM SABCS 2017

SOURCE: Dubsky P et al. SABCS 2017 Abstract GS6-04.

Pages

Recommended Reading

CDK4/6 inhibitors have similar efficacy in older breast cancer patients
MDedge ObGyn
VIDEO: SABCS 2017 roundtable with Dr. Hope S. Rugo and Dr. William J. Gradishar
MDedge ObGyn
High rate of arm morbidity in young breast cancer survivors
MDedge ObGyn
Postmenopausal women who shed pounds see lower breast cancer risk
MDedge ObGyn
Path CR signals good outcomes in treated high-risk breast cancers
MDedge ObGyn
DCIS risk signature is validated in SweDCIS population
MDedge ObGyn
ERBB2 expression predicts pCR in HER2+ breast cancer
MDedge ObGyn
Axillary node dissection can be avoided with limited SLN involvement
MDedge ObGyn
Pertuzumab approved for HER2-positive breast cancer
MDedge ObGyn
Enzalutamide plus exemestane improves PFS in HR+ breast cancer subset
MDedge ObGyn